What researchers study it for

• Oxidative stress in neurons grown in culture
• Rat pups exposed to high homocysteine before birth
• Alzheimer's disease cell models
• Binding of the peptide to DNA and histones

How it is thought to work

No mechanism has been established. In cell experiments, the peptide was linked to less build-up of reactive oxygen species, fewer cells dying by necrosis and a delay in ERK 1/2 activation. A 2020 review from the same group suggests it gets into cells and attaches to histones or nucleic acids, altering gene expression, but the authors themselves call this an assumption.

Where the research stands

Mostly preclinical; a few small Russian human reports. The bulk of the literature is cell and rat work from a single group. Human reports are small and appear chiefly in Russian-language journals. ClinicalTrials.gov lists no trials, and no FDA-approved product exists.

Sources

1. Khavinson V, et al. (2011). Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Research.
2. Arutjunyan A, et al. (2012). Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. International Journal of Clinical and Experimental Medicine.
3. Khavinson V, et al. (2020). EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease. Molecules.
4. Meshchaninov VN, et al. (2015). [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION]. Advances in Gerontology (Uspekhi Gerontologii).